Craig-Hallum Sticks to Their Buy Rating for Avid Bioservices (CDMO)
Avid Bioservices to Participate at Upcoming Investor Conferences
TUSTIN, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high
Avid Bioservices Currently Up 11 Consecutive Days, on Track for Longest Winning Streak on Record -- Data Talk
Avid Bioservices, Inc. (CDMO) is currently at $8.37, up $0.12 or 1.45% --Would be highest close since March 6, 2024, when it closed at $8.79 --Currently up 11 consecutive days; up 30.99% over this p
Avid Bioservices Is Maintained at Outperform by RBC Capital
Avid Bioservices Is Maintained at Outperform by RBC Capital
Express News | RBC Capital Maintains Outperform on Avid Bioservices, Raises Price Target to $8
Avid Bioservices Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/30/2024 11.42% RBC Capital $7 → $8 Maintains Outperform 03/11/2024 67.13% Stephens & Co. $15 → $12 Main
Analysts' Opinions Are Mixed on These Healthcare Stocks: Harmony Biosciences Holdings (HRMY), Decibel Cannabis Company (OtherDBCCF) and Avid Bioservices (CDMO)
Q3 2024 Avid Bioservices Inc Earnings Call
Analysts Offer Insights on Healthcare Companies: AIM ImmunoTech (AIM) and Avid Bioservices (CDMO)
Earnings Call: Avid Bioservices Sees Revenue Boost, Optimistic on Growth
Earnings Call Summary | Avid Bioservices(CDMO.US) Q3 2024 Earnings Conference
The following is a summary of the Avid Bioservices, Inc. (CDMO) Q3 2024 Earnings Call Transcript:Financial Performance:Avid Bioservices saw a significant increase in revenues by over 30% in Q3 2024 co
Avid Bioservices, Inc. (CDMO) Q3 2024 Earnings Call Transcript
Avid Bioservices, Inc. (CDMO) Q3 2024 Earnings Call Transcript
Avid Bioservices Q3 Financial Results Conference Call Announcement
Express News | Avid Bioservices Maintains FY24 Revenue Guidance Of $137M-$147M, Est $138.656M
Express News | Avid Bioservices Inc - Qtrly Shr Loss $ 0.09
Express News | Avid Bioservices Q3 Net Income USD -6 Million
Express News | Avid Bioservices Outlook FY Revenue USD 137-147 Million
Express News | Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024
Avid Bioservices 3Q Loss/Shr 9c >CDMO
Avid Bioservices 3Q Loss/Shr 9c >CDMO
Avid Bioservices 3Q Rev $33.8M >CDMO
Avid Bioservices 3Q Rev $33.8M >CDMO
No Data